🇺🇸 FDA
Patent

US 9937217

Method of inhibiting ABCG2 and related treatments

granted A61KA61K31/015A61K31/28

Quick answer

US patent 9937217 (Method of inhibiting ABCG2 and related treatments) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/015, A61K31/28, A61K31/4155, A61K31/439